Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 4.695\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a. CSCCC(NS(=O)(=O)c1ccc(C)cc1)C(=O)NCC(C)(C)N1CCOCC1
b. COc1ccc(-n2c(SCC(=O)N3CCOCC3)nc3ccccc3c2=O)cc1
c. COc1ccc(N2CCN(C(=O)c3cc(=O)c4cc(C)ccc4o3)CC2)cc1
d. CCOc1ccc(S(=O)(=O)N2CN3CCN(C3)C2)cc1
e. CC(On1nnc2ccccc21)C(=O)N1CCN(Cc2ccccc2)CC1
Answer: a. CSCCC(NS(=O)(=O)c1ccc(C)cc1)C(=O)NCC(C)(C)N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSCCC(NS(=O)(=O)c1ccc(C)cc1)C(=O)NCC(C)(C)N1CCOCC1
CSCCC(NS(=O)(=O)c1ccc(C)cc1)C(=O)NCC(C)(C)N1CCOCC1
N-(2-methyl-2-morpholin-4-ylpropyl)-2-[(4-methylphenyl)sulfonylamino]-4-methylsulfanylbutanamide